Clarity Medical Group Holding Limited (HKG:1406)
Hong Kong · Delayed Price · Currency is HKD 0.3550
+0.0200 (5.97%)
Apr 14, 2025, 9:50 AM HKT
HKG:1406 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| 188 | 359 | 496 | 637 | - | - | |
Market Cap Growth | -37.63% | -27.66% | -22.08% | - | - | - |
Enterprise Value | 84 | 227 | 300 | 575 | - | - |
Last Close Price | 0.35 | 0.68 | 0.94 | 1.25 | - | - |
Price Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
PE Ratio | - | - | - | 47.23 | - | - |
PS Ratio | 1.06 | 1.88 | 2.32 | 2.83 | - | - |
PB Ratio | 1.08 | 1.90 | 1.92 | 2.49 | - | - |
P/TBV Ratio | 1.08 | 1.90 | 1.92 | 2.49 | - | - |
P/FCF Ratio | - | - | - | 23.30 | - | - |
P/OCF Ratio | - | - | 30.60 | 23.13 | - | - |
EV Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
EV/Sales Ratio | 0.48 | 1.19 | 1.40 | 2.55 | - | - |
EV/EBITDA Ratio | - | - | - | 13.31 | - | - |
EV/EBIT Ratio | - | - | - | 16.20 | - | - |
EV/FCF Ratio | - | - | - | 21.02 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Debt / Equity Ratio | 0.11 | 0.13 | 0.18 | 0.08 | 0.15 | 0.28 |
Debt / EBITDA Ratio | - | - | 2.75 | 0.35 | 0.16 | 0.54 |
Debt / FCF Ratio | - | - | - | 0.74 | 0.19 | 0.96 |
Net Debt / Equity Ratio | -0.60 | -0.61 | -0.62 | -0.87 | -0.66 | -0.26 |
Net Debt / EBITDA Ratio | 3.82 | 2.88 | 103.85 | -5.12 | -0.97 | -0.69 |
Net Debt / FCF Ratio | 6.41 | 2.40 | 11.46 | -8.09 | -0.85 | -0.89 |
Asset Turnover | 0.69 | 0.68 | 0.69 | 1.11 | 1.55 | 1.75 |
Inventory Turnover | 20.68 | 27.91 | 25.06 | 20.90 | 15.20 | 18.03 |
Quick Ratio | 3.13 | 3.80 | 5.24 | 10.06 | 2.14 | 2.98 |
Current Ratio | 3.84 | 4.41 | 5.81 | 10.32 | 2.52 | 3.21 |
Return on Equity (ROE) | -35.80% | -33.77% | -1.24% | 8.03% | 35.20% | 32.72% |
Return on Assets (ROA) | -10.33% | -12.47% | -1.56% | 10.89% | 20.21% | 19.54% |
Return on Invested Capital (ROIC) | -60.57% | -65.18% | -11.58% | 81.16% | 63.64% | 54.46% |
Return on Capital Employed (ROCE) | -23.90% | -28.40% | -2.70% | 13.30% | 54.10% | 29.20% |
Yields
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Earnings Yield | -39.59% | -21.11% | -0.64% | 2.12% | - | - |
FCF Yield | -8.61% | -13.48% | -2.82% | 4.29% | - | - |
Payout Ratio | - | - | - | 192.72% | 14.69% | - |
Buyback Yield / Dilution | -0.25% | -0.50% | -33.76% | -4.15% | -33.67% | -3.67% |